Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Decheng Capital
Menlo Park, California, United Statesdecheng.com ↗
- Ownership
- Private
- Employees
- ~20
- Development stage
- Other
01
Overview
Decheng Capital does not develop drugs directly but invests in early-stage and growth-stage life science and healthcare companies globally. Its portfolio spans biopharma, diagnostics, tools, and medical devices. Many of its investments have reached IPO or been acquired by major pharmaceutical firms.
Recent notable investments include Aardvark Therapeutics ($85M Series C), Cellares ($255M Series C), Upstream Bio ($200M Series B), and Firefly Bio ($94M Series A).
Portfolio exits include acquisitions by Eli Lilly, Roche, Merck, Illumina, Vertex Pharmaceuticals, Regeneron and others.
The firm manages over $2 billion in capital with more than 100 investments since its founding in 2012.
Key people include founder Min Cui and managing directors Victor Tong Jr., Peter Colabuono; partners Dayton Misfeldt, Tony Tong, Y. Katherine Xu among others.
Headquarters are located at Menlo Park CA with a focus on both US and China markets.
No direct clinical pipeline as it operates as an investment/venture capital entity.
- Industry
- Investors
02
Partnerships
Versant VenturesMPM BioImpactAvoro Capital AdvisorsOrbiMed AdvisorsRTW InvestmentsEli Lilly & Company
Beyond the preview
Go deeper on Decheng Capital.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Decheng Capital.